Investigations on the molecular dosimetry of tobacco-specific N-nitrosamines.

S. S. Hecht, S. G. Carmella, N. Trushin, P. G. Foiles, D. Lin, J. M. Rubin, F. L. Chung

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Approaches for assessing molecular dosimetry of 4-(N-nitrosomethylamino)-1-(3-pyridyl)-1-butanone (NNK) and N'-nitrosonornicotine (NNN) in humans by measurement of haemoglobin or DNA adducts are discussed. NNK and NNN form haemoglobin adducts in Fischer 344 rats. Acid or base hydrolysis of the globin gives 4-hydroxy-1-(3-pyridyl)-1-butanone, which can be detected in rat blood up to six weeks after injection of NNK; it may be a useful marker for assessing uptake and metabolic activation of NNK and NNN in tobacco consumers. NNK and its major metabolite, 4-(N-nitrosomethylamino)-1-(3-pyridyl)-1-butanol (NNAI), methylated DNA of rat liver, lung and nasal mucosa to similar extents. NNAI is formed in human tissues from NNK, but immunoassays for O6-methyldeoxyguanosine (O6-medGuo) in exfoliated oral cells from snuff-dippers have been negative. NNK is also expected to form pyridyloxobutyl adducts in DNA; 32P-postlabelling assays for these adducts are being developed and appear to hold promise for detecting NNK- or NNN-DNA adducts in vivo.

Original languageEnglish (US)
Pages (from-to)423-429
Number of pages7
JournalIARC scientific publications
Issue number84
StatePublished - 1987
Externally publishedYes

Fingerprint Dive into the research topics of 'Investigations on the molecular dosimetry of tobacco-specific N-nitrosamines.'. Together they form a unique fingerprint.

Cite this